United-Guardian reported second quarter and first half 2026 financial results. Second quarter net sales rose 10% to $3,108,267 from $2,838,225 in the prior year period, with net income increasing 16% to $728,579 ($0.16 per share) from $626,826 ($0.14 per share). For the six-month period ended June 30, 2026, net sales increased 12% to $5,980,489 from $5,319,352, and net income grew 30% to $1,547,481 ($0.34 per share) from $1,187,721 ($0.26 per share). Growth was driven by a 44% increase in cosmetic ingredient sales, largely due to restocking by distributor Ashland Specialty Ingredients, and an 11% rise in pharmaceutical sales led by Renacidin. The company operates as a manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness products.

United-Guardian, Inc. declared a cash dividend of $0.30 per share, representing a 20% increase over the previous February dividend. The dividend is payable on August 4, 2026, to stockholders of record as of July 28, 2026. United-Guardian is a manufacturer of specialty cosmetic, personal care, and sexual wellness ingredients, as well as healthcare products including pharmaceuticals and medical lubricants.